Drugsoft


We provide drug applications (dictionary, interactions, pharmacovigilance), as well as drug databases and web services to doctors, pharmacists, hospitals and various entities involved in drug information.

Here are the latest news about our main Apps.

We have developed new apps for Android and iOS.

Android

We are now offering new applications developed with Kotlin, the language recommended by Google.

We can no longer provide updates for our old Flex/AIR apps due to an outdated security key structure no longer compatible with current Java versions. We are sorry for that. However we have provided free updates for more than 10 years.

iOS

We are also offering new iOS applications developed with SwiftUI, the new framework recommended by Apple.

We have updated our old Flex/AIR iOS apps most often on a monthly basis for several years. These drug data updates are essential to the security of our information. Unlike for Android updates, for iOS we have to go through a new validation process for each update. In recent months, and although only data changes, Apple's control systems fail to understand the simple concept of data updates. They are very often rejected randomly, sometimes fancifully, and idea exchange with the rejection board is difficult. As a result, we had to abandon some apps and we are sorry for that (eg abandonment of separate iPhone / iPad versions to avoid being marked as spam!).

To bypass these problems our new SwiftUI apps use direct API calls to our database server. No more need for Apple update validation. Our new Pharmacovigilance apps are approved (Hematox, Hepatox, Pancreatox) and they update old apps, as well as our Drug Interactions apps. Our French Medicines Dictionary was the last to be rejected (due to data on Covid19: SPC from the European Medicines Agency, a rather heartbreaking reason to disqualify a database on medicines) and we had to replace Covid19 by SARS-CoV-2 to get this application accepted.